CRP as an early indicator for anastomotic leakage after esophagectomy for cancer: a single tertiary gastro-esophageal center study
- PMID: 37964057
- PMCID: PMC10645624
- DOI: 10.1007/s00423-023-03176-w
CRP as an early indicator for anastomotic leakage after esophagectomy for cancer: a single tertiary gastro-esophageal center study
Abstract
Purpose: To determine the relationship between postoperative C-reactive protein (CRP) as an early indicator of anastomotic leakage (AL) after esophagectomy for esophageal cancer.
Methods: We reviewed patients diagnosed with esophageal or esophagogastric junctional cancer who underwent esophagectomy between 2006 and 2022 at the Karolinska University Hospital, Stockholm, Sweden. Multivariable logistic regression models estimated relative risk for AL by calculating the odds ratio (OR) with a 95% confidence interval (CI). The cut-off values for CRP were based on the maximum Youden's index using receiver operating characteristic curve analysis.
Results: In total, 612 patients were included, with 464 (75.8%) in the non-AL (N-AL) group and 148 (24.2%) in the AL group. Preoperative body mass index and the proportion of patients with the American Society of Anesthesiologists physical status classification 3 were significantly higher in the AL group than in the N-AL group. The median day of AL occurrence was the postoperative day (POD) 8. Trends in CRP levels from POD 2 to 3 and POD 3 to 4 were significantly higher in the AL than in the N-AL group. An increase in CRP of ≥ 4.65% on POD 2 to 3 was an independent risk factor for AL with the highest OR of 3.67 (95% CI 1.66-8.38, p = 0.001) in patients with CRP levels on POD 2 above 211 mg/L.
Conclusion: Early changes in postoperative CRP levels may help to detect AL early following esophageal cancer surgery.
Keywords: Anastomotic leakage; C-reactive protein; Esophageal cancer; Esophagectomy.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study.BMC Surg. 2021 Sep 21;21(1):348. doi: 10.1186/s12893-021-01344-7. BMC Surg. 2021. PMID: 34548054 Free PMC article.
-
Evaluation of preoperative risk factors and postoperative indicators for anastomotic leak of minimally invasive McKeown esophagectomy: a single-center retrospective analysis.J Cardiothorac Surg. 2019 Feb 28;14(1):46. doi: 10.1186/s13019-019-0864-4. J Cardiothorac Surg. 2019. PMID: 30819240 Free PMC article.
-
Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection.BMC Surg. 2020 Dec 9;20(1):324. doi: 10.1186/s12893-020-00995-2. BMC Surg. 2020. PMID: 33298038 Free PMC article.
-
Use of C-reactive protein for the early prediction of anastomotic leak after esophagectomy: Systematic review and Bayesian meta-analysis.PLoS One. 2018 Dec 17;13(12):e0209272. doi: 10.1371/journal.pone.0209272. eCollection 2018. PLoS One. 2018. PMID: 30557392 Free PMC article.
-
Diagnosing anastomotic leak post-esophagectomy: a systematic review.Dis Esophagus. 2021 Feb 10;34(2):doaa076. doi: 10.1093/dote/doaa076. Dis Esophagus. 2021. PMID: 33565590
Cited by
-
Biomarkers associated with anastomotic leakage after esophagectomy: a systematic review.Langenbecks Arch Surg. 2025 Jan 28;410(1):55. doi: 10.1007/s00423-025-03617-8. Langenbecks Arch Surg. 2025. PMID: 39875600 Free PMC article.
-
Influence of metabolic syndrome on prognosis of patients with surgically treated esophageal cancer: a meta-analysis.Diabetol Metab Syndr. 2024 May 23;16(1):111. doi: 10.1186/s13098-024-01335-7. Diabetol Metab Syndr. 2024. PMID: 38783372 Free PMC article. Review.
-
Clinical value of prognostic nutritional index combined with C-reactive protein and albumin in early prediction of anastomotic leakage after radical gastric cancer surgery.Am J Transl Res. 2024 Jul 15;16(7):3081-3089. doi: 10.62347/LDOZ1986. eCollection 2024. Am J Transl Res. 2024. PMID: 39114734 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet (London, England) 2012;379(9829):1887–1892. doi: 10.1016/S0140-6736(12)60516-9. - DOI - PubMed
-
- van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg. 2019;269(4):621–630. doi: 10.1097/SLA.0000000000003031. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous